Research: Breast Cancer Gene Screening Not Warranted For All

UNC-CH News Services

CHAPEL HILL -- Screening for mutations in a gene known as BRCA1 that is believed to predispose women to breast cancer should not be done routinely because the mutations are less prevalent than researchers thought, according to a new study.

Widespread screening of breast cancer patients or unaffected women in the absence of family history would waste considerable money and is more likely to yield results that are hard to interpret, say scientists at the universities of North Carolina at Chapel Hill and Washington at Seattle. Testing may be helpful for women from families in which both breast and ovarian cancer have occurred or in which at least four cases of breast cancer have been identified.

"Women who inherit an altered form of this gene from either parent are at increased risk of breast cancer sometime during their lives," said Dr. Beth Newman, assistant professor of epidemiology at the UNC-CH School of Public Health. "Most previous comparable research took place among patients attending specialized cancer clinics so it was estimated that between 11 percent and 20 percent of women carried a defective gene. We found the frequency of breast cancer due to BRCA1 to be considerably lower than that."

For the first time, Newman and colleagues studied women with breast cancer who were not selected on the basis of their age at diagnosis or their family medical history to develop a better estimate of how common mutations in the gene were. Included were 211 N.C. breast cancer patients, ages 20 to 74, and 188 women without the illness who served as controls. About half the subjects were white, and about half were black.

A report on the findings appears in Wednesday's (March 25) issue of the Journal of the American Medical Association.


Contact: David Williamson
University of North Carolina at Chapel Hill

Page: 1 2 3

Related biology news :

1. Research: Coral reefs decline actually began centuries ago
2. Research: U.S. boys also reaching puberty earlier than in past years
3. New Research: Children Inhale Higher Percentage Of Pollution
4. Progress In Prion Research: Three-Dimensional Structure Of Prion Protein Fully Uncovered
5. Breast cancer patients failed by treatment with taxol and taxotere respond to abraxane
6. Breastfeeding decreases infant mortality
7. Breast cancer study suggests role for tissue in carcinogenesis
8. Breast self examination increases womens concerns but has no effect on mortality
9. Breast cancer follow-ups no longer guess-work thanks to new physics research
10. Final media advisory for the 4th European Breast Cancer Conference (EBCC-4)
11. The 4th European Breast Cancer Conference (EBCC4)

Post Your Comments:

(Date:8/9/2019)... ... ... With a demand in healthcare to lower unneeded emergency room visits and ... (UCC) in the coming years, according to a new report on the industry by ... , is a detailed look at the current state of these healthcare outlets, including ...
(Date:8/6/2019)... ... 2019 , ... VetStem Biopharma has long been ... experience. In November it spun out a human regenerative medicine subsidiary, ... of the first cGMP cell manufacturing facilities in California , VetStem signed ...
(Date:8/6/2019)... ... August 05, 2019 , ... ... announce its attendance at the Microscopy & Microanalysis 2019 Meeting ( M&M 2019 ... Oregon Convention Center. , The Microscopy & Microanalysis Meeting, organized by the Microscopy ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... 2019 , ... Shoreline Biome, a microbiome research ... has announced partnerships with six international distributors. , The distributors will sell ... Australia, Benelux, Indonesia, Korea, Malaysia, Myanmar, New Zealand, Singapore, the United Kingdom, and ...
(Date:7/26/2019)... ... July 25, 2019 , ... LeadingBiotech , ... dialogue, today announces its Boston BD conference to be held on ... Biotech Week Boston , the event provides an opportunity for attendees to leverage ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for ... will have dedicated manufacturing space at the new, state-of-the-art commercial manufacturing center ...
(Date:7/2/2019)... ... , ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma , was recently ... film focuses on regenerative veterinary medicine as a means of improving the quality of ... in the Brentwood and Pacific Palisades International Film Festival in Los Angeles, California where ...
Breaking Biology Technology:
Cached News: